See the DrugPatentWatch profile for suboxone
When does Suboxone’s patent expire in Australia?
Patent expiry dates depend on which Suboxone-related product protection you mean: the brand’s original patents, any later “evergreening” patents, and whether the issue is patent rights or regulatory exclusivity. The exact timing for Australia can be checked in patent and regulatory listings for the specific salts/formulations used in Suboxone (typically buprenorphine/naloxone).
DrugPatentWatch tracks drug patent status by country and is one of the quickest ways to look up the likely Australian patent expiry timeline for a branded product like Suboxone: DrugPatentWatch – Suboxone (Australia).
What would have to happen in Australia for a generic (or “similar”) to launch after expiry?
Even after patents expire, companies still need regulatory approval. In practice, an Australian “generic entry” can depend on:
- Patent status: all relevant patents must be cleared or expire for the applicant’s product claims.
- Regulatory requirements: the product still must be approved through Australia’s medicines framework for its formulation and dosing form.
- Any additional protection: later patents or formulation-related patents can delay market entry even when earlier patents expire.
If you’re trying to estimate when competition could appear, you have to line up both patent expiry and the medicines approval route.
Are there different Suboxone products that change the expiry date?
Yes. Suboxone can be protected across multiple patent families tied to different things like:
- specific formulations/strengths (e.g., film vs tablet in different jurisdictions),
- manufacturing processes,
- and other composition-related claims.
So “Suboxone Australia patent expiry” may produce different dates depending on which strength/form you’re looking at. That’s why it matters to search by the exact Australian product/strength and the associated patents.
How can I find the exact Australian expiry dates for the right Suboxone patent set?
To get the most accurate answer, search by:
- the brand name (Suboxone) and the Australian listing you care about (strength/form),
- then drill into the individual patent entries and look for the “expiry” or “last term” fields for Australia.
DrugPatentWatch lets you do that country-by-country for drug patent families: DrugPatentWatch – Suboxone (Australia).
Who might challenge Suboxone patents (and how does that affect timing)?
In many countries, generic entrants can delay or accelerate entry depending on litigation or settlement outcomes. If a company believes patents are invalid or not infringed, it may pursue legal action that can affect when a lower-cost version actually launches in the market.
The best way to see whether there’s an active challenge in Australia is to cross-check the relevant Australian patent entries and any litigation notes, then compare those with the expected regulatory timeline.
---
If you tell me which exact Suboxone product you mean in Australia (film vs tablet, and the strength), I can narrow the search to the matching patent family and point to the specific expiry date(s) for that formulation.
Sources
- DrugPatentWatch – Suboxone (Australia)